ALNY

Alnylam Pharmaceuticals Inc (ALNY)

US
$ 291.68-0.1%

Price Chart

Key Statistics

Market Cap
$ 38.03B
P/E Ratio
0.00
Revenue (TTM)
$ 2.35B
Volume
625.02K
52W High
$ 304.39
52W Low
$ 146.79
Dividend Yield
0.00%
Beta
0.17

Technicals

50-Day MA
256.1114
200-Day MA
260.8073
52 Week High
304.39
52 Week Low
146.79

About ALNY

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Employees
2230
Headquarters
Cambridge, MA
CEO
Dr. Yvonne L. Greenstreet M.B.A., M.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg